Related Experiment Video
Updated: Oct 1, 2025

07:05
Injection of Porcine Adipose Tissue-Derived Stroma Cells via Waterjet Technology
Published on: November 23, 2021
2.0K
Stem Cell Application for Stress Urinary Incontinence: From Bench to Bedside.
Meng Liu1,2, Ying Wang1,2, Guo Gao3
1Department of Urology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.
Current Stem Cell Research & Therapy
|March 7, 2022
Summary
Autologous stem cell therapy shows promise for treating stress urinary incontinence (SUI) by addressing urethral sphincter dysfunction. This review explores various stem cell types for SUI treatment in experimental and clinical settings.
Area of Science:
- Regenerative Medicine
- Urology
- Cell Biology
Background:
- Stress urinary incontinence (SUI) is a prevalent global condition affecting urinary system health.
- Current treatments like medication and surgery manage symptoms but don't resolve underlying urethral sphincter dysfunction and can cause complications.
- Advances in cell technology offer potential for novel therapeutic approaches.
Purpose of the Study:
- To review the application of autologous stem cell therapy for stress urinary incontinence.
- To evaluate the efficacy of different stem cell types in treating SUI.
- To assess the current status of stem cell therapy for SUI in experimental and clinical research.
Main Methods:
- Literature review of studies on stem cell therapy for SUI.
- Analysis of experimental and clinical data on various stem cell types.
- Evaluation of stem cell mechanisms in restoring urethral sphincter function.
Main Results:
- Stem cell therapy is being investigated as a viable option for SUI treatment.
- Different stem cell types demonstrate potential in preclinical and clinical studies.
- Restoration of urethral sphincter function is a key target for stem cell interventions.
Conclusions:
- Autologous stem cell therapy presents a promising avenue for treating stress urinary incontinence.
- Further research and clinical trials are needed to optimize stem cell treatments for SUI.
- Cell-based therapies may offer a solution for patients with refractory SUI or complications from conventional treatments.

